Seminars in Oncology
Volume 33, Issue 2 , Pages 210-219, April 2006

Treatment of Relapsed Chronic Lymphocytic Leukemia: Old and New Therapies

  • John C. Byrd

      Affiliations

    • Corresponding Author InformationAddress correspondence to John C. Byrd, MD, Director of Hematologic Malignancies, Division of Hematology-Oncology, Starling Loving Hall, Room 302, The Ohio State University, Columbus, OH 43210, USA.
    • ,
  • Thomas S. Lin
    • ,
  • Michael R. Grever

Division of Hematology and Oncology, The Ohio State University, The Arthur James Comprehensive Cancer Center, Columbus, OH USA.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by the National Cancer Institute, The Leukemia and Lymphoma Society of America, and The D. Warren Brown Foundation.

PII: S0093-7754(06)00021-2

doi:10.1053/j.seminoncol.2006.01.012

Seminars in Oncology
Volume 33, Issue 2 , Pages 210-219, April 2006

Article Tools